Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:39 PM
Ignite Modification Date:
2025-12-24 @ 12:39 PM
NCT ID:
NCT02091661
Eligibility Criteria:
Inclusion Criteria:
* Age 75 years or younger
* Diagnosis of prostate cancer, as verified by cytologic or histologic examination the tumor is well differentiated to moderately well differentiated
* Untreated, clinically localized prostate cancer, with a tumor stage of T1, or T2
* Prostate specific antigen (PSA) level of ≤10 ng/ml
* Bone scan with no abnormalities
* Health status that would permit radical prostatectomy
* Life expectancy of more than 10 years.
Exclusion Criteria:
* PSA \>10 ng/ml
* Bone scan consistent with metastatic disease
* Other evidence that cancer of the prostate is not clinically localized
* Life expectancy less than 10 years
* Serum creatinine greater than 3 mg/dl
* Myocardial infarction within last 6 months
* Unstable angina Class III or IV
* Severe pulmonary disease
* Liver failure
* Severe dementia
* Debilitating illness Malignancies, except for nonmelanomatous skin cancer, in the last 5 years.
Healthy Volunteers:
False
Sex:
MALE
Maximum Age:
75 Years
Study:
NCT02091661
Study Brief:
Protocol Section:
NCT02091661